Incobotulinumtoxina Intramuscular and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Incobotulinumtoxina Intramuscular and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: incobotulinumtoxinA
Brand name: Xeomin
Synonyms: Incobotulinumtoxina (Intramuscular)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incobotulinumtoxina Intramuscular-Insulin degludec
- Incobotulinumtoxina Intramuscular-Insulin Degludec (U-100) Prefilled Pens
- Incobotulinumtoxina Intramuscular-Insulin Degludec (U-100) Vials
- Incobotulinumtoxina Intramuscular-Insulin Degludec (U-200) Prefilled Pens
- Incobotulinumtoxina Intramuscular-Insulin degludec and liraglutide
- Incobotulinumtoxina Intramuscular-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Increlex
- Insulin aspart, recombinant Subcutaneous-Incruse Ellipta
- Insulin aspart, recombinant Subcutaneous-Indacaterol
- Insulin aspart, recombinant Subcutaneous-Indacaterol and Glycopyrrolate
- Insulin aspart, recombinant Subcutaneous-Indacaterol and glycopyrrolate Inhalation
- Insulin aspart, recombinant Subcutaneous-Indacaterol inhalation